Perbio Science AB, Interim Report January - March 2002

Perbio Science AB Interim report January - March 2002 A strong start to the year · Net sales up 30% to SEK 552 (425) million · Operating profit before amortisation of goodwill up 33% to SEK 104 (78) million · Profit after financial items up 27% to SEK 95 (75) million. Last year's financial items included exchange gains of SEK 11 m, of which there were none this year; excluding these exchange gains, profit after financial items climbed 48% · Net profit up 29% to SEK 58 (45) million · Stronger market position: - Media factory completed in the USA - New raw material base for serum production thanks to acquisition from Selborne Biological Services in Australia - New BioProcess Container technologies thanks to acquisition from Float Mach in the USA "Perbio Science recorded net sales of SEK 552 million and pre-tax profit of SEK 95 million in the first quarter," says CEO Mats Fischier. "Our operating margin increased to 17.9% from 17.2% for 2001 as a whole. "Besides achieving strong earnings growth, Perbio continued to increase its market share. The acquisitions during the quarter and the new media factory have given us a stronger platform for continued rapid growth." FURTHER INFORMATION CEO Mats Fischier tel +46 42 26 90 91 or +46 70 595 18 21 CFO Claes Wenthzel tel +46 42 26 90 92 or +46 70 862 01 22 More information on Perbio Science can also be found on our website at www.perbio.com. ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2002/05/02/20020502BIT00150/wkr0001.doc http://www.waymaker.net/bitonline/2002/05/02/20020502BIT00150/wkr0002.pdf